A.Giaccari1 · G. Gliozzo1 · G. Ciccarelli1 · G. Di Giuseppe1 · C. Castellano2 · S. Cum3 · L. Delle Monache4,13 · M. Gallo5 ·M.Lastretti6 · G. Medea7 · M. Monesi8 · R. Napoli9 · B. Pintaudi10 · E. Succurro11 · G. Turchetti
Received: 9 January 2026 / Accepted: 17 March 2026 © The Author(s) 2026
Abstract
Background and aims Although continuous glucose monitoring (CGM) devices are now standard of care among Type 1 diabetes patients, they are still relatively underutilized in Type 2 diabetes (T2D), particularly in those patients not treated with insulin. Widespread adoption continues to be hindered by a combination of factors. Chief among these is the scarcity of long-term, large-scale clinical trials demonstrating the benefits of the use of CGM in T2D. This meta-analysis aimed to address this gap by comparing CGM with self-blood glucose monitoring (SBMG), with primary outcomes of HbA1c and time in range (TIR) in insulin-treated and non-insulin-treated TD2 patients.
Methods and results Following the stringent rules mandated by our National Health Service (which requires a panel com-posed of all stakeholders involved in diabetes treatment, and includes PICO, GRADE, AGREE, and meta-analyses), we performed a systematic review of RCTs that enrolled two groups of individuals with T2D, those treated with insulin (includ-ing basal and basal-bolus regimens), and those receiving treatments other than insulin. All included trials compared CGM with structured blood glucose monitoring (SBGM) with glycated hemoglobin (HbA1c) as the main endpoint. Based on the strength and consistency of the evidence, the panel issued a strong recommendation in favor of CGM for individuals with T2D treated with insulin (including those on basal insulin alone) and for individuals with T2D not treated with insulin, par-ticularly for those with glycated hemoglobin levels≥7%. From a pharmacoeconomic perspective, outcomes were positive in both patient groups.
Conclusion CGM represents a clinically effective and cost-efficient approach to optimizing glycemic control in T2D, becom-ing mandatory among individuals on insulin therapy. Our findings support a shift in clinical practice toward the more widespread use of CGM in T2D, with regulatory frameworks and reimbursement policies needing to adapt accordingly.
Keywords CGM · Type 2 Diabetes · Metanalysis · PICO · GRADE · Guidelines
Communicated by Massimo Federici, M.D.
A. Giaccari 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
1 Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy
2 Azienda USL of Modena, Sassuolo Hospital, Sassuolo, Italy
3 Diabetes and Diabetic Foot Care Unit, ASUGI, Monfalcone, Italy
4 National Board Member of FAND (Italian Association for the Rights of Diabetic People), Roma, Italy
5 Department of Endocrinology and Metabolic Diseases, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
6 Order of Psychologists of Lazio, Rome, Italy
7 Italian Society of General Medicine (SIMG), Florence, Italy
8 Territorial Diabetology Unit, AUSL Ferrara, Ferrara, Italy
9 Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
10 Diabetes Unit, Niguarda Cà Granda Hospital, Milan, Italy
11 Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy
12 Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy
13 Patient Advocacy Lab, ALTEMS – Università Cattolica del Sacro Cuore, Rome, Italy
版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章。
引用本文:简喜超, 简扬, 邓呈亮. 2025版《中国糖尿病足防治实践指南》解读[J]. 中华医学美学美容杂志, 2026, 32(2): 99-103. DOI: 10.3760/cma.j.cn114657-20251215-00266.
通信作者:邓呈亮,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
ABSTRACT: Links between nutrition and pressure ulcer (PU) prevention and wound healing are well known and documented (Saghaleini et al, 2018). Less well documented is the link between hydration and pressure care. It was recognised that many patients admitted to acute hospitals are dehydrated (El-Sharkawy et al, 2015); this is particularly relevant to Gastroenterology patients based on the classifications of dehydration (Posthauer, 2016), although all patients are at risk. Dehydration status is not routinely assessed without painful and costly blood tests. Through the use of an adapted version of the GULP Dehydration risk screening tool (Food First Nutrition and Dietetics Team, 2012) and the implementation of a hydration-focussed care plan, it may be possible for a nurse-led assessment to identify dehydration risk and plan care accordingly. A pilot study showed that 50% of the sample group gained an improved level of hydration throughout their hospital admission and a decrease in their Waterlow score.
KEY WORDS Dehydration risk assessment GULP risk assessment Hydration Pressure ulcer prevention Nurse-led care
KAREN GREEN Deputy Sister and Chief Nurse Fellow, University Hospitals of Leicester NHS Trust, Leicester, UK
The role of nutrition in both wound healing and pressure ulcer (PU) prevention is well documented (Saghaleini et al, 2018). However, what is less well known is the link between hydration, wound healing and PU prevention due to the effect of dehydration on blood volume and skin turgor. Fluids are responsible for providing transport of vitamins and nutrients to, and waste products away from, cells as well as allowing oxygen perfusion and hydration to wounds (Posthauer, 2012).
Classification of dehydration is as follows (Posthauer, 2012):
Isotonic dehydration — an equal loss of both water and sodium caused by diarrhoea and vomiting
Hypertonic dehydration — the loss of total body weight due to reduced water intake, pathologic fluid loss or both
Hypotonic dehydration — a predominant loss of sodium over water loss, resulting in extracellular fluid loss. This can occur due to renal disease, diuretic usage or reduced intake of both water and sodium.
Dehydration facts
Nearly two thirds of hospital admissions are of people over the age of 65 years old, 37% of these admissions are dehydrated on arrival to hospital, with 62% remaining so 48 hours after admission. (ElSharkawy et al, 2014). Dehydration can lead to an increased risk of mortality in patients who are acutely unwell and an increase in the risk of further illnesses including urinary tract infections (UTIs), seizures, acute kidney injury (AKI) and hypovolemic shock, as well as increasing the risk of PU and falls.
This all suggests that there needs to be more emphasis on prevention of dehydration and a proactive rather than a reactive approach is required.
In 2020, an acute gastroenterology (GI) ward at the Leicester Royal Infirmary was chosen to participate in the Trust's Pressure Ulcer Collaborative as part of a ‘Pathway to Excellence’ journey. Representatives from seven wards in the Trust came together to discuss their ward's achievements, and areas in which they needed development to improve the pressure area care they were providing.
Noting that many patients on a GI ward are dehydrated due to their illnesses and conditions, the acute GI ward chose to concentrate on the problem of dehydration. It was identified that, within the Trust, patients are not formally assessed for dehydration on admission or throughout their stay unless blood tests are taken, which causes discomfort to the patient and incurs a financial cost. As part of the collaborative a review was undertaken to determine if there was an existing risk assessment tool that could be piloted in the acute area.
WHAT IS GULP?
A review of available literature identified that a risk assessment exists and is used in community settings in some areas of the country; this is called the GULP dehydration risk screening tool and was developed by the Food First Nutrition and Dietetics Team (2012).
The original tool was developed for use in community settings and assesses three factors to gain an overall risk score of low, medium or high. This risk score is then used to implement the correct suggested plan of care based on the level of harm that continued dehydration poses:
G Gauge 24-hour fluid intake and measure against an identified requirement
U Urine colour
L Look for signs, symptoms and risk factors for dehydration
P Plan
It was determined that, with some modification, the assessment was suitable for use with inpatients in an acute hospital setting and written permission was obtained to adapt the tool accordingly from the Food First Team.
The adapted tool
G:The 24-hour fluid requirement was made more specific to an individual’s needs by using a person’s age and weight to identify their fluid requirement based on a formula of 30ml/kg of weight for patients 60 and over (Hodgkinson et al, 2003) and 35ml/kg for patients under 60 years old (Zeman, 1991) and adding an estimated guide of how many cups of drink are required to meet this, based on the cup size and a fluid estimation tool already in use within the Trust.
U: As many GI patients have dark urine due to jaundice, which may be unrelated to their dehydration status, this was highlighted on the urine colour assessment to reduce the incidences of false high scores in this category. Incontinence was also addressed, with the addition of monitoring of wet incontinence products and consideration of how strong the urine smells. A urine colour guide was also added.
L: The signs and symptoms of dehydration were reviewed and additions were made to account for patients who struggle to get to the toilet as fluid intake may be deliberately reduced by these patients. The use of thickened fluids was also added, as this can be a predisposing factor to poor oral intake as a result of patients' dissatisfaction with thickened fluids (McCurtin et al, 2018) due to the texture, taste and sensation as well as an increased feeling of satiety and thirst felt with their use (Cichero, 2013).
P: The low, medium and high-risk care plans were altered to make them more relevant to acute hospital settings.
Formal validation of the amended tool may need to be considered in the future.
Exceptions when using the tool
If a patient is started on IV fluids, only oral fluid intake is to be counted when assessing GULP scores (this includes intake via enteral feeding methods) If the patient is started on an oral fluid restriction for any reason, the assessments should be discontinued until the restriction is lifted
If a patient is nil by mouth (NBM) the assessment is put on hold until oral fluids are restarted (unless the patient is receiving enteral feed/fluid, in which case this should be counted as oral fluid intake).
The adapted tool was then peer reviewed by a Consultant Gastroenterologist, an Intestinal Failure Specialist Nurse and a Senior Dietician, who all gave constructive positive feedback.
How to complete the tool
1. Assess the patient’s oral intake for the previous 24 hours based on the provided minimal requirements – is it:
> their minimal requirement (Score 0)
< their minimal requirement but > 1000ml (Score 1)
< 1000ml (Score 2).
2. Assess the patient’s urine colour based on attached guide:
Colour 1–3, no smell, several wet pads a day (Score 0)
Unable to assess due to non-adherence/jaundice, smells at times, only 1–2 wet pads a day (Score 1)
Colour 4–8, very strong smell, pads only slightly wet (Score 2).
3. medical conditions or medications which predispose the patient to dehydration:
Score 0, 1 or 2 based on the guidance information on the risk assessment.
4. Scores are totalled to give an overall risk of Low, Medium or High.
5. Appropriate care plan can then be initiated based on patient score.
Figure 1. Adapted GULP dehydration risk assessment, by Deputy Sister Karen Green
THE PILOT
For the pilot, 6 patients in one bay were selected and had their GULP score reviewed on Tuesdays and Saturdays for the duration of their stay (Figure 2). There were 6 patients chosen. This allowed for a variety of GI conditions to be observed within the selected bay, on a randomised basis, while still allowing concise monitoring conditions to ensure high levels of compliance with the tool and associated identified care plan. A pilot study is defined by Porta (2008) as:
"A small scale test of the methods and procedures to be used on a larger scale.”
Informed consent was obtained from all patients in this pilot study for non-patient identifiable data to be collected, recorded, and compared and for the appropriate care plan to be implemented. As this data was collected on tools and assessments already recognised and in use within the Trust such as fluid balance charts (FBC) and the Waterlow risk assessment tool it was not necessary to gain ethical approval to add this data to the GULP tool. The tool did not replace routine blood tests during the trial.
RESULTS
It was noted that 5 of the 6 patients in the pilot study were dehydrated on admission to hospital as indicated by their GULP risk assessment score. On discharge 3 of these 5 patients had a lower GULP risk score than on admission suggesting an improved hydration level. There were 2 patients who remained at the same risk level. Throughout the study, no patients had a decline in their dehydration status or developed AKI.
Although the pilot was only conducted on 6 patients, it indicated that it is possible to identify patients who are dehydrated or at risk of dehydration earlier on in their admission and monitor them easily throughout their stay. Furthermore, through the early implementation of a basic hydration-specific care plan, none of those at risk of dehydration within the pilot group developed AKI during their admission.
In 50% of the sample group, as the patient’s GULP score went down so did their Waterlow (Figure 3). This limited pilot was therefore considered successful, as a positive correlation was shown in half the sample group. Pilot studies when designed and conducted well may give an indication of the likely outcome of a larger trial (van Teijlingen and Hundley, 2002).
Next steps
On the basis of the successful pilot, the initiative is moving forward to an extended although still limited patient group to ascertain whether the tentative results from the pilot are replicated in a larger patient group over an extended period.
The tool was to be used on all suitable admissions to the GI ward over a 6-month period between 1 July 2021 and 31 December 2021. This data will then be collated to identify whether the reduced Waterlow scores seen in the initial pilot are replicated on a larger scale. The incidence of PUs on the ward during this 6-month period will also be compared with the incidence of PU during the same 6-month period for the previous three years (2020, 2019 and 2018), as well as to those of a control ward, also GI in speciality for the 6-month trial period. Following this, the tool will potentially be used in other specialities to extend the pilot further.
Limitations
The initial pilot was incredibly limited and was carried out as such to test the efficiency and usability of the tool before a larger pilot took place over an extended period. The tool has only been used in GI medicine and so it is not clear whether the same results will be obtained in different acute specialities throughout the Trust. The tool was initially met with some resistance from ward staff and, due to the Trust operating a paperless system, the tool was occasionally missed during regular patient assessment.
Declaration of interest
There are no conflicts of interest.
REFERENCES
1. Cichero JA (2013) Thickening agents used for dysphagia management: effect on bioavailability of water, medication and feelings of satiety. Nutr J 12: 54. https://doi.org/10.1186/1475-2891-12-54.
2. El-Sharkawy AM, Watson P, Neal KR et al (2015) Hydration and outcome in older patients admitted to hospital (The HOOP prospective cohort study). Age Ageing 44(6):943-7. https://doi.org/10.1093/ageing/afv119
3. Food First Nutrition and Dietetics Team, South Essex Partnership University NHS Foundation Trust (2012) GULP Dehydration Risk Screening Tool. https://tinyurl.com/mds2db2u (accessed 3 September 2022)
4. Hodgkinson B, Evans D, Wood J (2003) Maintaining oral hydration in older adults: a systematic review. Int J Nurs Pract 9(3):S19–S28. https:// doi.org/10.1046/j.1440-172x.2003.00425.x
5. McCurtin A, Healy C, Kelly L et al (2018)Plugging the patient evidence gap: what patients with swallowing disorders post-stroke say about thickened liquids. IJLCD 53(1):30–39. https://doi.org/10.1111/1460- 6984.12324
6. Porta M. A Dictionary of Epidemiology (5th edn). Oxford University Press, 2008
7. Posthauer ME (2012) Dehydration and wound healing: know the facts. [Weblog] Wound Source. https://tinyurl.com/2s3a3epj (accessed 3 September 2022)
8. Saghaleini SH, Dehghan K, Shadvar K et al (2018) Pressure ulcer and nutrition. Indian J Crit Care Med 22(4):283–9. https://doi. org/10.4103%2Fijccm.IJCCM_277_17
9. van Teijlingen E, Hundley V (2002) The importance of pilot studies. Nurs Stand 16(40):33–6. https://doi.org/10.7748/ns2002.06.16.40.33.c3214
10. Zeman FJ . Clinical Nutrition and Dietetics. 2nd edn. Macmillan Publishing Company: NewYork
This article is excerpted from the Wounds UK | Vol 18 | No 3 | 2022 by Wound World.
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。